RA Capital Management, L.P. 13D/13G Filings for Achilles Therapeutics plc (ACHL)

RA Capital Management, L.P. 13D and 13G filings for Achilles Therapeutics plc:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-12-30
4:57 pm
Sale
2022-12-2813DAchilles Therapeutics plc
ACHL
RA Capital Management, L.P.1,607,834
13.000%
-1,369,109decrease
(-45.99%)
Filing
2022-12-23
5:15 pm
Sale
2022-12-2113DAchilles Therapeutics plc
ACHL
RA Capital Management, L.P.2,976,943
13.000%
-1,130,565decrease
(-27.52%)
Filing
2022-12-15
5:01 pm
Sale
2022-12-1313DAchilles Therapeutics plc
ACHL
RA Capital Management, L.P.4,107,508
13.000%
-907,179decrease
(-18.09%)
Filing
2021-04-16
4:34 pm
Purchase
2021-04-0613DAchilles Therapeutics plc
ACHL
RA Capital Management, L.P.5,014,687
12.340%
5,014,687increase
(New Position)
Filing